Malin Corporation | MLC - Ativo Circulante





Ativo Circulante Alterar Data
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
ALKERMES USD 1.93B 187.5M 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Eurofins Scientific SE EUR 2.65B 34.2M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
Lonza CHF 8B 3.41B 2025-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Moderna USD 6.54B 54M 2025-12
Organon & Co USD 4.7B 82M 2025-09
Ovoca Bio EUR 1.56M 3.39M 2025-06
Revvity USD 2.24B 95.96M 2025-12
Tectonic Therapeutic USD 257.36M 15.88M 2025-12
Viatris USD 9.79B 162.2M 2025-12
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12